Weiss Multi-Strategy Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-60,000	Closed	-$494K	–	585
2015 Q1	$494K	Sell	60,000 -15,000	-20%	-$111K	0.02%	368
2014 Q4	$515K	Buy	75,000 +15,000	+25%	+$93.8K	0.02%	340
2014 Q3	$324K	Buy	+60,000	New	+$350K	0.01%	471
2014 Q2	–	Sell	-26,310	Closed	-$212K	–	1056
2014 Q1	$212K	Sell	26,310 -99,670	-79%	-$776K	﹤0.01%	904
2013 Q4	$859K	Buy	125,980 +15,980	+15%	+$86.3K	0.02%	467
2013 Q3	$2.02M	Sell	110,000 -10,000	-8%	-$194K	0.04%	338
2013 Q2	$2.1M	Buy	+120,000	New	+$2.13M	0.06%	319

Other funds holding ARIA

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ARIA Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 60,000 shares — an estimated $494K sold.

Weiss Multi-Strategy Advisers first reported a position in ARIA in Q2 2013 and held it in 7 quarters. The position peaked at $2.1M in Q2 2013. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

Weiss Multi-Strategy Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 60,000 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $494K.
Weiss Multi-Strategy Advisers first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Ariad Pharmaceuticals Inc position peaked at $2.1M in Q2 2013.
177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.